European Neuropsychopharmacology
Volume 19, Issue 9 , Pages 659-669, September 2009

Conditioned place preference induced by social play behavior: Parametrics, extinction, reinstatement and disruption by methylphenidate

  • Viviana Trezza
  • ,
  • Ruth Damsteegt
  • ,
  • Louk J.M.J. Vanderschuren

      Affiliations

    • Corresponding Author InformationCorresponding author. Rudolf Magnus Institute of Neuroscience, Dept. of Neuroscience and Pharmacology, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, The Netherlands. Tel.: +31 88 7568811; fax: +31 88 7568155.

Rudolf Magnus Institute of Neuroscience, Dept. of Neuroscience and Pharmacology, University Medical Center Utrecht, Utrecht, The Netherlands

Received 19 January 2009; received in revised form 12 March 2009; accepted 31 March 2009. published online 12 May 2009.

Abstract 

In this study, we investigated behavioral factors underlying conditioned place preference (CPP) induced by social interaction in adolescent rats. We found that the magnitude of socially-induced CPP depended on the social motivation of the animals and on the amount of training. After extinction, socially-induced CPP could be reinstated by a single reconditioning session. Treatment with methylphenidate, which disrupts social play behavior in adolescent rats, but not social exploratory behavior, prevented the development of socially-induced CPP. Interestingly, methylphenidate by itself induced CPP. These data demonstrate that: 1. social interaction is rewarding in adolescent rats; 2. appetitive and mnemonic factors influence the development of socially-induced CPP; 3. comparable to drug-induced CPP, socially-induced CPP can be extinguished and reinstated; 4. social play is likely to be the most rewarding aspect of social interaction in adolescent rats; 5. social context influences the subjective effects of methylphenidate.

Keywords: Social behavior, Adolescence, Place conditioning, Methylphenidate, Reward, Motivation, Reinstatement

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0924-977X(09)00093-5

doi:10.1016/j.euroneuro.2009.03.006

European Neuropsychopharmacology
Volume 19, Issue 9 , Pages 659-669, September 2009